Sao Paulo, Brazil —— Singclean Medical, a world-leading absorbable biomaterial company, appeared at HOSPITALAR 2025 in June 2025, bringing four major product lines including regenerative medical beauty, orthopedics, ophthalmology and surgical hemostasis, to systematically demonstrate its global strength driven by the dual core of "R&D + automation" to the Latin American market. As a benchmark exhibition in the Latin American medical industry, this HOSPITALAR brings together top companies from around the world. Singclean medical has become one of the core concerns of professional audiences on site with its CE/NMPA/ANVISA multi-certified product matrix and localized cooperation results.

Regenerative technology leads the way, and the compliant product matrix is recognized by the market

The regenerative medical beauty product line featured in the Singclean medical booth (D-138) has sparked heated discussions with its solid evidence-based medical data and full-process compliance:

Regenerative medical beauty series: including PDRN cell repair technology, PLLA long-acting collagen stimulator, Meishen needle (CaHA/HA composite gel) and Bingbing needle (HA compound double amino acid), adapted to the climate and skin characteristics of Latin America.

Core medical devices:

Modified Sodium Hyaluronate Gel for Injection (medical anti-adhesion sodium hyaluronate gel)

Singfiller® (Cross-linked Sodium Hyaluronate Gel for Plastic Surgery) (cross-linked sodium hyaluronate medical beauty filler)

Absorbable hemostatic microspheres and medical sodium hyaluronate gel (orthopedics/ophthalmology), covering surgery and chronic disease management scenarios.

"Singclean medical has a complete product certification system and clear technical documents, which is very important in the Latin American market," said a representative of a regional distributor in Brazil. "We have introduced its medical beauty products to local medical beauty institutions, and doctors have reported that the operation is convenient and the effect is stable."

Hardcore production and R&D: the cornerstone of global quality

Singclean medical's manufacturing and innovation capabilities provide solid guarantees for its global layout:

Production advantages

International standard intelligent manufacturing: The entire production line has passed the ISO 13485 quality management system certification, and the key processes are completed in a Class 100 clean workshop. The German OPTIMA filling equipment and the Swedish Getinge sterilization system are used to ensure product sterility and consistency.

Capacity guarantee: 

The annual production capacity exceeds 12 million sets, which can quickly respond to global order needs.

R&D advantages

High R&D investment: More than 10% of revenue is invested in innovation each year, with 25 invention patents and 23 utility model patents.

Industry-university-research collaboration:

 Cooperate with institutions such as Zhejiang University and the National University of Singapore Suzhou Research Institute to focus on the technology of absorbable materials.

National platform: 

National postdoctoral research workstation, promoting the efficient transformation of laboratory results to clinical practice.

Localization and in-depth cultivation: 

full-chain empowerment from certification to service

Singclean medical's layout in the Brazilian market has achieved phased results:

Certification first: Currently, 6 products have passed ANVISA registration, covering the fields of medical beauty, orthopedics, and ophthalmology. More products are planned to be localized and certified in 2025.

Dealer network: Establish cooperation with high-quality dealers in Brazil to provide full-cycle services from technical training to after-sales support, helping products to quickly penetrate into core medical terminals.

Clinical adaptation: Aiming at the high incidence of osteoarthritis and trauma surgery in Latin America, optimize the wet and hot environment performance parameters of absorbable hemostatic materials and joint lubrication products.

"We are discussing customized packaging and logistics solutions with Singclean medical to further improve supply chain efficiency," said a Brazilian partner distributor. "Their responsiveness and technical support are impressive."

Future Outlook: Sustainable Innovation Drives Growth

Singclean medical will continue to deepen its "Global R&D + Regional Adaptation" strategy:

Expand the scale of cooperation with Brazilian distributors to promote the popularization of regenerative medical aesthetics and orthopedic products in private hospitals and clinics.

Relying on the HOSPITALAR Hub platform, we provide online technical training and academic resources to strengthen local clinical service capabilities.

"The globalization of healthcare is essentially the globalization of technology and trust," said Singclean medical's global marketing director. "We will build a sustainable medical ecosystem with our Latin American partners with more pragmatic product strength and localized services."

Media Contact

Mars Wu, Media Director

Email: support@singclean.net

#HOSPITALAR2025